Genetic and host factors for dementia in Down's syndrome
- 1 May 2002
- journal article
- review article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 180 (5) , 405-410
- https://doi.org/10.1192/bjp.180.5.405
Abstract
The high risk for dementia in adults with Down's syndrome has been attributed to triplication and overexpression of the gene for amyloid precursor protein (APP). But the wide variation in age at onset must be due to other risk factors. To identify factors which influence age at onset of dementia in Down's syndrome. Studies of factors which influence formation of beta-amyloid (Abeta) were reviewed, including atypical karyotypes, susceptibility genotypes, gender and oestrogen deficiency, and individual differences in Abeta peptide levels. The apolipoprotein E epsilon4 allele, oestrogen deficiency and high levels of Abeta1-42 peptide are associated with earlier onset of dementia, while atypical karyotypes and the apolipoprotein E epsilon2 allele are associated with reduced mortality and reduced risk of dementia. Factors which influence Abeta levels, rather than overexpression of APP, may account for the differences in age at onset of dementia in Down's syndrome.Keywords
This publication has 72 references indexed in Scilit:
- Molecular mapping of alzheimer‐type dementia in Down's syndromeAnnals of Neurology, 1998
- Increased plasma amyloid β protein 1–42 levels in Down syndromeNeuroscience Letters, 1998
- The epidemiology of Alzheimer disease in intellectual disability: results and recommendations from an international conferenceJournal of Intellectual Disability Research, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's diseaseThe Lancet, 1996
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseThe Lancet, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's DiseaseNew England Journal of Medicine, 1989